Cruise ship hantavirus outbreak turns into a global contact tracing test

2. The episode is clinically important because Andes virus is the only hantavirus with documented person-to-person transmission, although it does not behave like a highly transmissible airborne pathogen.

The Andes virus outbreak linked to the MV Hondius expedition cruise ship has become one of the more unusual travel medicine events of 2026. The Dutch-flagged ship departed Ushuaia, Argentina, in April and was later associated with a cluster of severe respiratory illness among passengers and crew. A correspondence in the New England Journal of Medicine described a cluster of cruise ship-associated Andes virus infections, including fatal cases and rapid progression in some patients. Standard respiratory pathogen panels were negative, and diagnosis required pan-hantavirus reverse transcription polymerase chain reaction (RT-PCR), with sequencing used to confirm Andes virus. That diagnostic detail matters because these patients can initially resemble severe viral pneumonia, influenza-like illness, or other travel-associated respiratory infections. Illness was characterized by fever, gastrointestinal symptoms, pneumonia, acute respiratory distress syndrome, and shock in severe cases. The World Health Organization reported more than 600 contacts across 32 countries, territories, and areas under close monitoring or self-monitoring as of late May. Andes virus is notable because it is the only hantavirus known to spread from person to person. Even so, the World Health Organization clarified that the transmission pattern is not consistent with highly transmissible airborne pathogens such as measles. That distinction is important for risk communication. The event warrants careful contact tracing and clinician awareness, but it does not imply broad community spread in the way a respiratory virus with high airborne transmissibility would. For frontline clinicians, the practical lesson is to keep hantavirus cardiopulmonary syndrome in the differential when a returning traveler has febrile onset, gastrointestinal symptoms, rapidly progressive respiratory failure, and negative standard panels after travel in South America. The 42-day monitoring window used for exposed travelers reflects uncertainty around the incubation period for person-to-person Andes virus transmission. The exact transmission mode aboard the ship, whether close respiratory contact, contaminated environments, or a combination, remains under investigation. This outbreak is a reminder that global travel can turn a rare regional zoonosis into a multinational surveillance challenge within days.